Literature DB >> 17311698

Hereditary colorectal cancer syndromes: an overview.

Eunice L Kwak1, Daniel C Chung.   

Abstract

Approximately 5% of the 140,000 cases of colorectal cancer diagnosed annually are attributable to an underlying hereditary colorectal cancer syndrome. However, this is likely to be an underestimation. Our understanding of the genetic basis, as well as the guidelines for clinical management of these syndromes, continue to evolve rapidly. Because of the high risk of not only colorectal cancer but also multiple extracolonic tumors, it is crucial for clinicians to recognize the unique features in the diagnosis and management of these high-penetrance syndromes, including familial adenomatous polyposis, MYH-associated polyposis, and hereditary nonpolyposis colon cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17311698     DOI: 10.3816/CCC.2007.n.002

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


  9 in total

Review 1.  Psychosocial Impact of Lynch Syndrome on Affected Individuals and Families.

Authors:  Polymnia Galiatsatos; Heidi Rothenmund; Sylvie Aubin; William D Foulkes
Journal:  Dig Dis Sci       Date:  2015-03-19       Impact factor: 3.199

2.  Morphologic and molecular events at the invading edge of colorectal carcinomas.

Authors:  Carlos A Rubio
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 3.  MYH polyposis syndrome: clinical findings, genetics issues and management.

Authors:  M Sereno; M Merino; M López-Gómez; C Gómez-Raposo; F Zambrana Tébar; J Moreno Rubio; J Espinós; S Martín-Algarra; E Casado Sáenz
Journal:  Clin Transl Oncol       Date:  2014-03-19       Impact factor: 3.405

4.  Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors.

Authors:  Jalaj Gupta; Ana Igea; Marilena Papaioannou; Pedro Pablo Lopez-Casas; Elisabet Llonch; Manuel Hidalgo; Vassilis G Gorgoulis; Angel R Nebreda
Journal:  Oncotarget       Date:  2015-04-20

Review 5.  Mutator/Hypermutable fetal/juvenile metakaryotic stem cells and human colorectal carcinogenesis.

Authors:  Lohith G Kini; Pablo Herrero-Jimenez; Tushar Kamath; Jayodita Sanghvi; Efren Gutierrez; David Hensle; John Kogel; Rebecca Kusko; Karl Rexer; Ray Kurzweil; Paulo Refinetti; Stephan Morgenthaler; Vera V Koledova; Elena V Gostjeva; William G Thilly
Journal:  Front Oncol       Date:  2013-10-29       Impact factor: 6.244

6.  Phenotypicand Genotypic Characterization of Clinical Isolates of Intracellular Adherent-Invasive Escherichia coli Among Different Stages, Family History, and Treated Colorectal Cancer Patients in Iran.

Authors:  Razie Kamali Dolatabadi; Hossein Fazeli; Mohammad Hassan Emami; Vajihe Karbasizade; Fatemeh Maghool; Alireza Fahim; Hojatollah Rahimi
Journal:  Front Cell Infect Microbiol       Date:  2022-07-11       Impact factor: 6.073

7.  The Activation of the Tumor Suppressor Protein p53 by Acriflavine Leads to Mitochondrial Dysfunction and Improves the Radiosensitivity of Colon Cancer Cells.

Authors:  Caizhao Lin; Xiaohua Chen; Huayun Qiu; Benfeng Li; Min Guo
Journal:  J Immunol Res       Date:  2022-07-29       Impact factor: 4.493

8.  High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer.

Authors:  Emmanuel Buc; Damien Dubois; Pierre Sauvanet; Jennifer Raisch; Julien Delmas; Arlette Darfeuille-Michaud; Denis Pezet; Richard Bonnet
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

9.  Scaphium affine Ethanol Extract Induces Anoikis by Regulating the EGFR/Akt Pathway in HCT116 Colorectal Cancer Cells.

Authors:  Hye Won Kawk; Gun-He Nam; Myeong Jin Kim; Sang-Yong Kim; Young-Min Kim
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.